Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer.

Thu-Huyen PhamYesol BakTaeho KwonSae-Bom KwonJae-Wook OhJong-Hyung ParkYang-Kyu ChoiJin Tae HongDo-Young Yoon

Published in: Cell communication and signaling : CCS (2019)

Our findings demonstrate a novel role of IL-32θ as an intracellular modulator to suppress macrophage-promoted breast cancer progression by targeting CCL18-dependent signaling.

Keyphrases

adipose tissue
liver injury
liver fibrosis
drug induced
reactive oxygen species
young adults